be_ixf;ym_202411 d_26; ct_50

Latest Insights on FB

dual threat stock market strategy Find Refuge From This Dual Threat Time to start “dialing back.” That’s how Mary Daly, president of the San Francisco Fed, views the Federal Reserve’s stimulus measures. Daly sees less need for support, and she’s hardly alone in her view. No fewer than eight other Fed presidents have voiced a similar assessment recently. That’s because they are confident about the ongoing economic recovery. The first place they will start is the Federal Reserve’s massive $8.2 trillion balance sheet, which has swelled by 100% since the pandemic began. But those views are at odds with the surge in new COVID-19 cases as the delta variant spreads.
agricultural robotics Profit as Robots Infiltrate Farming With This 1 ETF In yesterday’s Your Money Matters video, Angela Jirau, Clint Lee and I talked about the revolutionary potential of automation and robotics to increase productivity in the U.S. economy in the coming decade. Increasing productivity — getting more from an hour of labor — is a solution to almost every economic problem. In the long run, population and productivity growth drive economic growth. Given a fixed amount of capital and labor, growing productivity is the only way to increase output.
profit from the robotics boom Profit From the Coming Surge in Robotics and Automation The delta variant is draining the global economy and destroying consumer confidence. Democrats are struggling to get their infrastructure bill through. And recovery stocks are suffering as a result. But today, we look beyond the bad news and explore the opportunities waiting on the other side.
why nfts are hot right now Here’s Why NFTs Are Hot Right Now The NFT world is going bananas right now. Here’s what you need to know about this part of the crypto market.
investing safely in biotech The Secret to Investing Safely in Biotech Biotech is back — new vaccines, new technologies. It's certainly tempting for the average investor to try to stake a claim right now. But as enticing as those stories about lifesaving drugs and potential profits may seem, biotech investing is risky business. I learned a painful — but powerful — lesson myself that I'd like to share with you. In today’s video, you'll see that there is a better, safer way to play this biotech boom ... all while collecting enormous dividends.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Thirteen of my positions are up well over 50% in less than a year since joining your service. Two are in the triple digits with several close behind. My personal money manager, who works for one of the largest banks in the country, is envious of my gains. I never dreamed this was possible. My trips to China to teach English to young Chinese students is now much more affordable. Thank you for your dedication and help.”

- Chris K.

"You have done once again!! You are reminding me of the GREAT Joe DiMaggio with your consistent hitting!! You knocked this one out of the park!"

- Keith S.

"You told me to ignore the noise on Wall Street. And thanks to you, I started towards the end of 2016 with $200,000 in my account and I recently put in an extra $100,000. [As of February 2019] My account is worth $500,788! I would’ve missed out if I followed conventional wisdom."

- Helen C.

Share This